Body Fluid Analysis Market to Reach $3.65 Billion by 2031
The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031, at a CAGR of 6.9% during the forecast period. Market growth is primarily driven by the increasing global incidence of infectious, neurological, and oncological diseases, which is creating sustained demand for advanced diagnostic solutions.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51260937
In...
Molecular Cytogenetics Market to Reach $1.43 Billion by 2030
The global molecular cytogenetics market is projected to grow from USD 1.02 billion in 2025 to USD 1.43 billion by 2030, at a CAGR of 7.1% during the forecast period. Market growth is primarily driven by the increasing incidence of cancer and genetic disorders, along with a growing emphasis on targeted therapies and personalized medicine.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148469224
Advancements...
PDX Model Market: Driving Precision Oncology and Next-Generation Drug Discovery
The global PDX model market is projected to grow from USD 0.37 billion in 2025 to USD 0.66 billion by 2030, registering an impressive CAGR of 12.5%. The major factors driving the growth in the PDX model market include the rising demand for clinically relevant preclinical models that closely replicate human tumor biology and therapeutic response. Additionally, growth in the PDX model market is being...
Molecular Diagnostics Market to Reach $30.74 Billion by 2030
The global molecular diagnostics market is estimated at USD 19.48 billion in 2025 and is projected to reach USD 30.74 billion by 2030, growing at a CAGR of 9.6% during the forecast period. Market expansion is driven by increasing investments in research and development, rising awareness of early disease detection, and the growing importance of personalized medicine.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=833
Molecular...
Top Companies Driving Innovation in the Long-Read Sequencing Market
The global long-read sequencing market is witnessing unprecedented growth as advancements in genomic research continue to transform healthcare, precision medicine, and biotechnology. According to industry estimates, the market is projected to grow from USD 758 million in 2024 to USD 3,129 million by 2029, registering an impressive CAGR of 32.8% during the forecast period.
The rapid expansion of...
Immunohistochemistry Market to Reach $5.14 Billion by 2030
The global Immunohistochemistry (IHC) market is projected to grow from USD 3.55 billion in 2025 to USD 5.14 billion by 2030, at a CAGR of 7.6% during the forecast period. Growth in the market is primarily driven by the increasing demand for advanced diagnostic techniques, particularly in oncology, along with favorable reimbursement policies in developed regions.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=121632939
Comprehensive...
Microfluidics Market to Reach $37.2 Billion by 2030
The global microfluidics market is projected to grow from USD 24.96 billion in 2025 to USD 37.2 billion by 2030, at a CAGR of 8.3% during the forecast period. Market growth is being driven by the increasing adoption of point-of-care (PoC) diagnostics, advancements in biotechnology, and expanding applications in drug delivery systems.
Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1305
Microfluidic...
Recombinant Proteins Market Growth, Trends, and Forecast 2028: Driving Innovation in Biologics and Precision Medicine
The global recombinant proteins market is witnessing significant growth as advancements in biotechnology, increasing demand for biologics, and rising focus on personalized medicine reshape the healthcare landscape. The market was valued at USD 2.2 billion in 2023 and is projected to reach USD 3.2 billion by 2028, growing at a CAGR of 7.2% during the forecast period from 2023 to 2028.
The expanding...
Biopharmaceutical Contract Manufacturing Market: Accelerating Innovation, Scale, and Global Biologics Supply
The global biopharmaceutical contract manufacturing market is undergoing a powerful transformation, driven by the rapid expansion of biologics, increasing demand for personalized therapies, and the growing reliance on specialized outsourcing partners. Valued at USD 22.40 billion in 2025, the market is projected to grow at a strong CAGR of 8.8% over the forecast period, reflecting its critical role...
Single-Use Bioprocessing Market: Driving Efficiency and Flexibility in Biopharmaceutical Manufacturing
The biopharmaceutical industry is undergoing a rapid transformation, with manufacturers increasingly seeking flexible, cost-effective, and scalable production solutions. At the forefront of this shift is the Single-Use Bioprocessing Market, which is redefining how biologics, vaccines, and advanced therapies are developed and manufactured.
The market is projected to grow from USD 18.01 billion in...